Friday, April 7, 2017

Pharma Reviews: Indian pharma cos get 55 final ANDA approvals from US FDA in Q1 of 2017

Higher investments in R&D during last couple of years has started yielding good results for R&D based Indian phrma companies in current year.
Read more: Indian pharma cos get 55 final ANDA approvals from US FDA in Q1 of 2017